EpiAge Research Publication Signals a New Era in Understanding Biological Aging
FOR IMMEDIATE RELEASE Singapore – January 9, 2025 – EpiMedTech Global, a leader in genetic and epigenetic innovation, is excited
January 11, 2025
Category: Press Releases
EpiMedtech Global Announces FDA Registration of EPIAGE, the First Epigenetic Age Test Registered by the FDA
November 18, 2024 – Singapore – EpiMedtech Global, a leader in genetic and epigenetic testing, is proud to announce that
November 18, 2024
EpiMedTech Global Validates Unique epiCervix HPV Combo Test for Cervical Cancer Detection
Singapore, November 18 2024 — EpiMedTech Global Singapore is thrilled to announce the successful validation of our groundbreaking Epicervix HPV
November 18, 2024
HKG epiTherapeutics’ MetaGen Genetic Risk Assessment Test Receives FDA Registration, Now Available in the U.S.
FOR IMMEDIATE RELEASE Singapore – October 31, 2024 – Epi Med Tech Global, a pioneer in genetic and epigenetic testing,
October 31, 2024
EpiMedTech Global Launches epiGeneComplete: A Breakthrough Genetic and Epigenetic Test for Comprehensive Health Diagnostics
FOR IMMEDIATE RELEASE Revolutionizing the early detection of health risks through cutting-edge DNA methylation and genetic analysis. Singapore, 2024-10-30 –
October 31, 2024
Enhanced Early Detection of Liver Cancer
EpiMedTech Global, a biotech company developing early disease detection tests, announced today the validation of its new test for early
October 30, 2024
EpiMedTech Global to Present at the 150th National Investment Banking Association Conference Slated for September 4-5 in Ft. Lauderdale
Singapore – News File Corp. – August 27, 2024 – EpiMedTech Global, a company focused on revolutionizing healthcare through real-world
August 27, 2024
EpiMedTech Global Featured in Coverage of NIBA’s 150th Investment Conference
EpiMedTech Global Featured in Coverage of NIBA’s 150th Investment Conference EpiMedTech Global, a pioneering company dedicated to transforming healthcare through
August 21, 2024
HKG Epitherapeutics Ltd. Secures CLIA Registration Certificate, A Significant Step Forward in Clinical Laboratory Services
HKG Epitherapeutics Ltd receives CLIA certification, a testament to its dedication to excellence in clinical laboratory testing. Discover the impact
June 18, 2023
Pioneering High-Throughput Assay for Swift Detect of Liver Cancer Unveiled by HKG Epitherapeutics Ltd and Collaborat
Discover the groundbreaking high-throughput test developed by HKG Epitherapeutics and partners for the early detection of Hepatocellular Carcinoma. Utilizing distinctive
June 12, 2023
